Experiments were conducted in order to assess the healing effect of bee venom (BV) cream on full-thickness skin wounds in rabbits. BV cream was compared with silver sulfadiazine (SS) as a topical medicament against a control on experimentally created full-thickness wounds. Two wounds measuring 2 × 2 cm were created bilaterally (four wounds/rabbit) on the dorsolateral aspect of the trunk of seven New Zealand white rabbits. Wound treatments were evenly distributed on four sites, using a Latin square design. The contact layer of wounds was treated with physiological saline (control), SS cream, and BV cream over a period of 28 days. Assessment of wound healing was based on scab hardness, wound exudates, wound area, unepithelialized granulation tissue, and histopathological findings. Topical application of BV and SS creams to wounds resulted in reduced inflammation, debridement of necrotic tissue, and promoted granulation and epithelialization. Wound healing was faster, with statistical significance in BV and SS treatments, compared to the control (P<0.05). Treatment with BV evoked an anti-inflammation effect in a rabbit model. BV cream produced a wound healing effect similar to that of commercially available SS cream. Anti-inflammation effect as a topical treatment with BV cream appears to be better than that with SS cream. These results suggest that topical application of BV cream may be an alternative treatment for full-thickness skin wounds.

A 14-year-old intact female, mixed dog was presented with hematuria and strangury. Mass in the abdominal cavity was seen on radiographs and ultrasound. On the cytological examination in the urethra, clusters of pleomorphic epithelial cell were found. Tissues of the urethra and the urinary bladder were obtained at the time laparotomy and determined the extent of the mass. Transitional cell carcinoma (TCC) of the urinary bladder was found in histopathologic characteristics. Urinary diversion after removal of a complete full section of the TCC in bladder wall was performed. Piroxicam, as a medical therapy for TCC, was orally administrated. Surgical operation and chemotherapy were selected with the goal of maintaining and improving quality of life.